Skip to content
Start Your Quest
Uncategorized

NRNP 6635 Anxiety Disorders Comprehensive Evaluation

5 min read

Anxiety disorders are common in NRNP 6635 evaluations, and the challenge is distinguishing among them and ruling out medical and substance causes. This guide walks through a comprehensive anxiety disorders evaluation, including generalized anxiety disorder, panic disorder and social anxiety disorder, with a fictional case and an evidence-based plan.

Quick answer

Identify the anxiety pattern: generalized worry for at least six months (GAD), recurrent unexpected panic attacks (panic disorder) or fear of social scrutiny (social anxiety disorder). Rule out thyroid disease, caffeine, stimulants, withdrawal and cardiac causes, quantify severity with the GAD-7 and recommend CBT and/or SSRIs or SNRIs as first-line treatment while limiting benzodiazepines.

The patient in this guide is fictional and is used for study purposes only. Diagnostic criteria are summarized in our own words; consult the DSM-5-TR directly for exact criteria, and base your evaluation on your assigned case.

The Case

Case summary

Fictional case: L.P., a 41-year-old accountant, reports eight months of constant worry about work, her children’s safety and finances. She says, “My mind never shuts off.” She describes restlessness, muscle tension, irritability, difficulty concentrating and trouble falling asleep. She denies sudden panic attacks or avoidance of social situations. She drinks four cups of coffee daily. GAD-7: 15. TSH normal. MSE: tense, fidgeting, anxious affect, linear thought process, no suicidal ideation, good insight.

Distinguishing Anxiety Disorders (Summarized)

DisorderCore featureDuration
Generalized anxiety disorderExcessive, hard-to-control worry about multiple areas, with at least 3 of 6 associated symptoms in adultsAt least 6 months
Panic disorderRecurrent unexpected panic attacks with persistent concern or behavior changeAt least 1 month after an attack
Social anxiety disorderMarked fear of situations involving possible scrutinyTypically at least 6 months
Specific phobiaMarked fear of a specific object or situationTypically at least 6 months
AgoraphobiaFear of situations where escape may be difficultTypically at least 6 months

Source: American Psychiatric Association (2022). L.P. meets criteria for GAD; see the criterion-by-criterion comparison in how to compare DSM-5-TR criteria.

Differential Diagnoses

  1. Generalized anxiety disorder: eight months of multi-domain worry with four associated symptoms.
  2. Substance/medication-induced anxiety disorder (caffeine): four cups daily may contribute; recommend gradual reduction and reassess.
  3. Major depressive disorder: screen with the PHQ-9 because depression and anxiety frequently co-occur.

Also consider anxiety due to another medical condition, such as hyperthyroidism (TSH normal here) or arrhythmia when palpitations are prominent.

Treatment Plan

  • Psychotherapy: cognitive behavioral therapy is a first-line, evidence-based treatment for anxiety disorders (Szuhany & Simon, 2022).
  • Pharmacotherapy: SSRIs and SNRIs are first-line medications; start low, titrate and allow several weeks for response (Szuhany & Simon, 2022).
  • Benzodiazepines: avoid routine long-term use because of dependence, cognitive effects and fall risk, especially with alcohol or opioid use or in older adults.
  • Lifestyle: reduce caffeine, improve sleep habits and encourage regular physical activity.
  • Measurement: repeat the GAD-7 to monitor response (Spitzer et al., 2006).

Frequently Asked Questions

What is the minimum duration for GAD?

At least six months of excessive worry occurring more days than not, according to DSM-5-TR.

Are benzodiazepines first-line for anxiety?

No. CBT and SSRIs or SNRIs are first-line; benzodiazepines carry risks and are generally reserved for limited situations.

How do I measure anxiety severity?

The GAD-7 is a brief, validated measure commonly used to screen and monitor generalized anxiety.

Get Help With Your Anxiety Disorders Evaluation at Collepals

Comprehensive psychiatric evaluations take time, and NRNP 6635 often requires a new one every few weeks. Collepals.com supports PMHNP students with:

  • Guidance on organizing your case into the comprehensive psychiatric evaluation template.
  • Help comparing DSM-5-TR criteria and building three well-supported differential diagnoses.
  • Current, evidence-based references formatted in APA 7.
  • Model evaluations, case presentations and reflections you can study, plus editing and proofreading of your drafts.

Browse our free model assignments or learn more about our nursing assignment writing service.

Get NRNP 6635 help at Collepals.com

Use Collepals examples as study guides and follow your university’s academic integrity and AI policies when you submit your own work.

More NRNP 6635 study guides

  • NRNP 6635 Comprehensive Psychiatric Evaluation: Complete Guide
  • How to Develop Three Differential Diagnoses in Psychiatric Evaluations
  • How to Compare DSM-5-TR Criteria in Psychiatric Case Studies
  • NRNP 6635 Major Depressive Disorder Case Study
  • How to Develop a Psychiatric Treatment Plan Using DSM-5-TR

Collepals is an independent study resource and is not affiliated with or endorsed by Walden University. Course requirements, templates and rubrics change; always follow your current syllabus and course template. This article is educational and is not clinical advice for any individual patient.

References

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787

Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097. https://doi.org/10.1001/archinte.166.10.1092

Szuhany, K. L., & Simon, N. M. (2022). Anxiety disorders: A review. JAMA, 328(24), 2431–2445. https://doi.org/10.1001/jama.2022.22744

Academic Writer & Editor
WhatsApp